- Trusted Weight Loss Support at the Most Competitive Prices!
Yes, you can switch, and doing so is both safe and common practice. Our expert team will make sure your transition is smooth and tailored to your needs.
Wegovy has become significantly more affordable than Mounjaro in the UK following a price adjustment by the manufacturer.
Clinical trials show that users of Wegovy (semaglutide) typically lose about 15% of their body weight over 68 weeks, with around 10.3% loss at 6 months.
• Wegovy is the first GLP‑1 medicine approved for cardiovascular benefits.
• It doesn't interfere with oral contraceptives.
• It tends to cause fewer injection site reactions.
Eli Lilly raised UK prices to align with mainland Europe, making Wegovy a more cost-effective option.
Absolutely. With prices starting around £119 per month, Wegovy offers a less expensive alternative that still maintains strong effectiveness.
As of July 2025, Mounjaro shows higher average weight loss in studies. However, Wegovy still delivers meaningful, lasting results—and a higher 7.2 mg dose coming later this year has shown up to 21% weight loss, with one-third of users losing a quarter of their weight. Side effects were similar to the standard dose.
Wegovy and Mounjaro work similarly. If you were tolerating Mounjaro well, you’re less likely to experience new side effects after switching. Common side effects include nausea, digestive disturbances, fatigue, or headaches; they’re usually mild and temporary.
A slight slowdown is possible—but outright weight gain is rare. Many users continue to lose weight steadily, or even pick up momentum again. Staying consistent with injections is key.
Absolutely. Our clinically-led team will guide your dose adjustment and provide ongoing access to support resources including tips and help managing any side effects.
We understand that consistency is crucial for your weight loss journey. That’s why we offer personalised dose planning and check-ins, and access to a comprehensive guide, all designed to help you transition seamlessly and continue making steady progress.
